ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

HR Technology & Analytics Specialist at Mineralys Therapeutics - ApplyBlast

HR Technology & Analytics Specialist

Mineralys Therapeutics

5 days ago

Remote

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The HR Technology and Analytics Specialist supports and optimizes HR technology platforms, primarily Workday, while delivering workforce reporting, analytics, and insights. This hybrid role partners with HR, Finance, IT, and business stakeholders to translate business needs into scalable system solutions and improved HR processes. The position involves providing functional support, contributing to system enhancements, and maintaining the quality and security of HR data.

Responsibilities

Provide functional support and configuration for Workday HCM and HR technology platforms
Design and develop Workday reports, dashboards, and calculated fields for workforce analytics
Maintain HR data quality, governance standards, and security across the organization

Skills

Qualifications

Bachelor's degree in Human Resources, Information Systems, Business, Analytics, or related field

About Mineralys Therapeutics

mineralystx.com

Headquarters

Radnor, Pennsylvania, United States

Company Size

11-50 employees

Founded

2020

View Profile

Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on improving outcomes for people with hypertension, chronic kidney disease (CKD), and cardio-renal-metabolic diseases driven by dysregulated aldosterone. The company's lead investigational candidate, Lorundrostat, is designed to target the underlying role of aldosterone in these conditions. Mineralys is advancing its pipeline through clinical development with the goal of delivering better outcomes for patients inadequately served by current therapies.